MyFinsight
Home
Blog
About
Short-term investments
$135,682K
(-28.05%↓ Y/Y)
Accounts receivable, net
$46,839K
(86.42%↑ Y/Y)
Inventories
$11,689K
(33.77%↑ Y/Y)
Prepaid expenses and
other current assets
$9,137K
(22.78%↑ Y/Y)
Cash and cash
equivalents
$8,163K
(-84.16%↓ Y/Y)
Total current assets
$211,510K
(-24.85%↓ Y/Y)
Inventories, noncurrent
$19,045K
(42.40%↑ Y/Y)
Intangible assets, net
$13,900K
(7.15%↑ Y/Y)
Other assets
$2,955K
(-3.15%↓ Y/Y)
Property, plant and
equipment, net
$2,085K
(93.95%↑ Y/Y)
Total assets
$249,495K
(-20.41%↓ Y/Y)
Total liabilities and
stockholders' equity
$249,495K
(-20.41%↓ Y/Y)
Total liabilities
$236,983K
(95.61%↑ Y/Y)
Total stockholders'
equity
$12,512K
(-93.49%↓ Y/Y)
Accumulated deficit
-$417,560K
(-106.58%↓ Y/Y)
Accumulated other
comprehensive (loss) gain, net
-$140K
(-204.35%↓ Y/Y)
Term loans, net
(including related party...
$96,676K
Financing liability
$74,927K
(4.12%↑ Y/Y)
Total current
liabilities
$60,863K
(33.47%↑ Y/Y)
Other accrued
liabilities
$3,402K
(139.92%↑ Y/Y)
Contract liability, net
of current portion
$1,115K
(1.09%↑ Y/Y)
Additionalpaid-incapital
$430,202K
(9.05%↑ Y/Y)
Common stock, 0.0001
par value per share...
$10K
(0.00%↑ Y/Y)
Accounts payable and
accrued liabilities...
$59,732K
(34.94%↑ Y/Y)
Other current
liabilities
$596K
Contract liability,
current
$535K
(-28.28%↓ Y/Y)
Back
Back
Balance Sheet
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)
source: myfinsight.com